AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TELIX PHARMACEUTICALS LTD

15.015

-0.345-2.25%

Volume:530.59K

Turnover:7.98M

Market Cap:5.09B

PE:112.94

High:15.300

Open:15.220

Low:14.860

Close:15.360

52wk High:18.320

52wk Low:8.260

Shares:338.72M

Float Shares:275.41M

Volume Ratio:1.43

T/O Rate:0.19%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.133

EPS(LYR):-0.029

ROE:7.36%

ROA:2.71%

PB:7.48

PE(LYR):-510.58

Loading ...

Overview Company News Filings

Telix Reports First Patients Dosing in Prostate Cancer Trial

MT Newswires Live

Citi Sees Positive Catalysts for Telix Pharmaceuticals

3 ASX Growth Stocks Investors Are Watching After Sharp Pullbacks

Simply Wall St.

Telix Stock And Two ASX Growth Picks Backed By Insider Ownership

Simply Wall St.

3 Fast Growing ASX Stocks With High Insider Ownership to Watch

Simply Wall St.

ASX Biggest Losers

MT Newswires Live

Fast Growing Australian Stocks Where Insider Ownership Signals Real Skin In The Game

Simply Wall St.

Champion Iron Stock And 2 Fast Growing Insider Owned Picks

Simply Wall St.

High Insider Ownership Stocks With Real Growth Potential In Australia

Simply Wall St.

Stock Track | Telix Pharmaceuticals Soars 5.15% Intraday on Positive FDA Feedback and Strong Insider Buying

3 ASX Growth Companies With Up To 34% Insider Ownership

Simply Wall St.

Fast Growing Australian Stocks With High Insider Ownership Worth A Closer Look

Simply Wall St.

Telix Pharmaceuticals Securing FDA Nod in Line With Expectations, Says Jefferies, Shares Down 3%

MT Newswires Live

Telix Pharmaceuticals (ASX:TLX) Clears FDA Trial Step, Does It Look Fairly Valued?

Simply Wall St.

Jefferies Sees Australia's Telix on Track for Timely U.S. Entry After Prostact FDA Clearance

Telix Pharmaceuticals Says FDA Alignment to Advance Prostact Global Phase 3 Trial

Australia's Telix Rises to over 9-month High as FDA Backs Prostact Study Advancement

Telix Pharmaceuticals Gets US FDA Nod to Advance Phase 3 Prostate Cancer Trial

MT Newswires Live

Telix Pharmaceuticals - Initiation of Part 2 in U.S. Subject to FDA Ind Amendment Review

THOMSON REUTERS

Telix Pharmaceuticals Ltd-fda Alignment to Advance Prostact Global Phase 3 Trial

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/TLX.AU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","market":"AU","secType":"STK","nameCN":"TELIX PHARMACEUTICALS LTD","latestPrice":15.015,"timestamp":1788227574641,"preClose":15.36,"halted":0,"volume":530587,"delay":0,"changeRate":-0.022460937499999927,"nameEN":"TELIX PHARMACEUTICALS LTD","floatShares":275410996,"shares":338721355,"eps":0.1329429014238407,"marketStatus":"Trading","change":-0.345,"latestTime":"09-01 11:53:07 AEST","open":15.22,"high":15.3,"low":14.86,"amount":7983722,"amplitude":0.028646,"askPrice":15.02,"askSize":885,"bidPrice":15.01,"bidSize":926,"shortable":3,"etf":0,"ttmEps":0.1329429014238407,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788242400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":15.36,"openAndCloseTimeList":[[1788220800000,1788242400000]],"volumeRatio":1.431423,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"TLX.AU","preClose":15.36,"auctionPrice":15.22,"auctionVolume":15532,"auctionTime":1788220747790,"referenceTime":1788172203092,"auction":1,"marketStatus":"盘前竞价","timestamp":1788220747790}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","floatShares":275410996,"roa":"2.71%","roe":"7.36%","lyrEps":-0.029408,"volumeRatio":1.431423,"shares":338721355,"dividePrice":0,"high":15.3,"amplitude":0.028646,"preClose":15.36,"low":14.86,"week52Low":8.26,"pbRate":"7.48","psRate":"4.10","week52High":18.32,"institutionHeld":0,"latestPrice":15.015,"committee":0.022639,"eps":0.1329429014238407,"divideRate":0,"volume":530587,"delay":0,"ttmEps":0.1329429014238407,"open":15.22,"prevYearClose":11.2,"prevWeekClose":15.65,"prevMonthClose":15.36,"prevQuarterClose":16.58,"fiveDayClose":16.16,"twentyDayClose":14.41,"sixtyDayClose":13.39},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-20","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787184000000,"name":null,"time":"","dateTimestamp":1787148000000,"actualEps":null},{"date":"2026-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771455600000,"name":null,"time":"","dateTimestamp":1771419600000,"actualEps":null},{"date":"2026-01-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768777200000,"name":null,"time":"","dateTimestamp":1768741200000,"actualEps":null},{"date":"2025-08-21","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739919600000,"name":null,"time":"","dateTimestamp":1739883600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX.AU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651967224","title":"Telix Reports First Patients Dosing in Prostate Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2651967224","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651967224?lang=en_us&edition=fundamental","pubTime":"2026-07-16 04:58","pubTimestamp":1784149110,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  said late Wednesday the first patients with metastatic hormone-sensitive prostate cancer have been dosed with TLX597-Tx in a phase 2 trial at St Vincent's Hospital in Sydney, Australia.The OPTIMAL-e trial will evaluate TLX597-Tx in earlier prostate cancer treatment setting, building on the OPTIMAL-PSMA2 study which recently completed patient enrollment, the firm said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLX","TLX.AU","BK7067","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651748293","title":"Citi Sees Positive Catalysts for Telix Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2651748293","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651748293?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:06","pubTimestamp":1784070360,"startTime":"0","endTime":"0","summary":"2305 GMT - Telix Pharmaceuticals' stock looks a good bet to outperform over the next month, suggests Citi. That's despite a 41% rise in its share price since the start of the year. \"We open a positive 30-day catalyst watch on Telix as we think 2Q delivery will be robust and potentially ahead of consensus,\" analyst Laura Sutcliffe says. Citi also sees support for Telix's stock as it approaches the potential resubmission of kidney-cancer imaging agent Zircaix and potential approval and launch of brain-cancer imaging agent Pixclara. It rates Telix at \"buy, high-risk.\"  Dow Jones NewswiresJuly 14, 2026 19:06 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX","TLX.AU","BK7067","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651810194","title":"3 ASX Growth Stocks Investors Are Watching After Sharp Pullbacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2651810194","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651810194?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:28","pubTimestamp":1784060937,"startTime":"0","endTime":"0","summary":"With inflation, energy shocks and shifting interest rate expectations all pulling markets in different directions, many investors are looking for growth stories that management itself is confident enough to own. That is exactly what the Fast Growing Stocks With High Insider Ownership screener is built to highlight by filtering for companies where analysts see solid growth potential and insiders have committed their own capital. This combination can help you focus on businesses where outlook...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/3-asx-growth-stocks-investors-are-watching-after-sharp-pullb","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/3-asx-growth-stocks-investors-are-watching-after-sharp-pullb","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LIN.AU","BK4211","BK7067","TLX.AU","PDI.AU","BK7095","BK7104","ISBC","TLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651143971","title":"Telix Stock And Two ASX Growth Picks Backed By Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2651143971","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651143971?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:26","pubTimestamp":1783945618,"startTime":"0","endTime":"0","summary":"With oil prices, global bond yields and inflation expectations all in focus, a lot of attention is on interest rates and how companies handle a more volatile cost of capital. In this setting, many investors are looking at fast growing stocks where insiders hold meaningful stakes, which can help align management with shareholders when conditions are choppy. Our Fast Growing Stocks With High Insider Ownership screener highlights companies where growth expectations from analysts and management...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/telix-stock-and-two-asx-growth-picks-backed-by-insider-owner","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/telix-stock-and-two-asx-growth-picks-backed-by-insider-owner","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4570","BK7095","PPI","BK7104","TLX","TLX.AU","BK7067","PDI.AU","BK4139","LIN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650378150","title":"3 Fast Growing ASX Stocks With High Insider Ownership to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2650378150","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650378150?lang=en_us&edition=fundamental","pubTime":"2026-07-12 12:26","pubTimestamp":1783830409,"startTime":"0","endTime":"0","summary":"Fast growing stocks with high insider ownership can be especially interesting when inflation trends, interest rate expectations and geopolitical tensions are all pulling markets in different directions. With investors watching oil prices, bond yields and earnings reports so closely, this screener focuses on companies where growth is a key part of the story and management has significant skin in the game. That combination can appeal if you want exposure to growth, but also care about alignment...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/3-fast-growing-asx-stocks-with-high-insider-ownership-to-wat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/3-fast-growing-asx-stocks-with-high-insider-ownership-to-wat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TLX","TLX.AU","BK4139","BK7104","PDI.AU","BK7067","LIN.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650253905","title":"ASX Biggest Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2650253905","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650253905?lang=en_us&edition=fundamental","pubTime":"2026-07-10 10:14","pubTimestamp":1783649689,"startTime":"0","endTime":"0","summary":"Here are the ASX-listed companies with the biggest losses on Friday.Electro Optic Systems Holdings : -6%, AU$8.38Pro Medicus : -5%, AU$199.56Tamboran Resources : -4%, AU$0.23Elevra Lithium : -4%, AU$8.67Austal : -4%, AU$3.77EVT : -3%, AU$12.33Telix Pharmaceuticals : -3%, AU$16.36Marimaca Copper : -3%, AU$7.51SiteMinder : -3%, AU$3.79Codan : -3%, AU$43.25","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SDR.AU","MC2.AU","ELV.AU","BK7142","BK7067","BK7016","BK7110","CDA.AU","BK7084","BK7094","EVT.AU","BK7115","ASB.AU","BK7035","PME.AU","BK7095","TLX.AU","TBN.AU","EOS.AU"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2650190382","title":"Fast Growing Australian Stocks Where Insider Ownership Signals Real Skin In The Game","url":"https://stock-news.laohu8.com/highlight/detail?id=2650190382","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650190382?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:44","pubTimestamp":1783629853,"startTime":"0","endTime":"0","summary":"With inflation, interest rates and energy prices pulling markets in different directions, many investors are looking for companies where growth plans and insider incentives are clearly aligned. The Fast Growing Stocks With High Insider Ownership screener focuses on businesses that analysts and management teams both view positively, and where insiders hold meaningful stakes in the stock. That combination can help you focus on companies where growth is a central priority and leadership is...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/fast-growing-australian-stocks-where-insider-ownership-signa","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/fast-growing-australian-stocks-where-insider-ownership-signa","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XKO.AU","IISV.AU","DACE.AU","XAO.AU","TLX.AU","BK7067","E200.AU","PDI.AU","GEAR.AU","EIGA.AU","VAS.AU","XJO.AU","QRE.AU","BK7095","OZR.AU","IIGF.AU","BK7104","SLF.AU","IMLC.AU","BK4139","TLX","IOZ.AU","OZF.AU","LIN.AU","ZYAU.AU","VAP.AU","STW.AU","QFN.AU","BBOZ.AU","GIVE.AU","BEAR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649955071","title":"Champion Iron Stock And 2 Fast Growing Insider Owned Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2649955071","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649955071?lang=en_us&edition=fundamental","pubTime":"2026-07-08 06:31","pubTimestamp":1783463508,"startTime":"0","endTime":"0","summary":"With inflation expectations tied to oil prices, central banks weighing rate moves and growth signals mixed across major economies, many investors are looking for companies where management is clearly aligned with shareholders and focused on expansion. That is the idea behind the Fast Growing Stocks With High Insider Ownership screener, which highlights businesses that combine growth potential with management teams that hold meaningful stakes in their own stock. This article walks through...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2055000-choice2-main-header/1585186660639","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2055000-choice2-main-header/1585186660639"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-cia/champion-iron-shares/news/champion-iron-stock-and-2-fast-growing-insider-owned-picks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-cia/champion-iron-shares/news/champion-iron-stock-and-2-fast-growing-insider-owned-picks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TLX.AU","TLX","BK7067","BK4139","GUNR","BK7129","BK4588","CIA.AU","LIN.AU","BK4585","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649556673","title":"High Insider Ownership Stocks With Real Growth Potential In Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2649556673","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649556673?lang=en_us&edition=fundamental","pubTime":"2026-07-06 20:34","pubTimestamp":1783341267,"startTime":"0","endTime":"0","summary":"With global growth signals mixed, inflation pressures easing in places, and central banks reassessing their next moves, investors are paying closer attention to companies that can grow on their own steam. The Fast Growing Stocks With High Insider Ownership screener focuses on businesses where both analysts and management see optimistic prospects, and where insiders hold a meaningful stake alongside you. That combination can help you focus on growth potential that is closely watched by those...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/high-insider-ownership-stocks-with-real-growth-potential-in","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/high-insider-ownership-stocks-with-real-growth-potential-in","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["E200.AU","IMLC.AU","QFN.AU","BK7145","LIN.AU","BEAR.AU","BK4139","EIGA.AU","QRE.AU","VAS.AU","XJO.AU","GIVE.AU","STW.AU","OZR.AU","DACE.AU","IIGF.AU","IISV.AU","XKO.AU","IOZ.AU","XAO.AU","BBOZ.AU","BK7067","BK7095","VAP.AU","GLF.AU","OZF.AU","TLX","GEAR.AU","TLX.AU","SLF.AU","ZYAU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159033409","title":"Stock Track | Telix Pharmaceuticals Soars 5.15% Intraday on Positive FDA Feedback and Strong Insider Buying","url":"https://stock-news.laohu8.com/highlight/detail?id=1159033409","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159033409?lang=en_us&edition=fundamental","pubTime":"2026-07-06 12:54","pubTimestamp":1783313666,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals Limited (ASX:TLX) saw its stock price surge 5.15% during intraday trading on Monday, reflecting strong investor interest in the biopharmaceutical company.The price movement...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649619107","title":"3 ASX Growth Companies With Up To 34% Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2649619107","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649619107?lang=en_us&edition=fundamental","pubTime":"2026-07-06 03:08","pubTimestamp":1783278496,"startTime":"0","endTime":"0","summary":"As the Australian market opens the new financial year on a flat note, global influences such as geopolitical tensions and tech sector enthusiasm continue to shape investor sentiment. In this landscape, growth companies with high insider ownership can be particularly appealing, as they often signal strong internal confidence and alignment with shareholder interests.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/3-asx-growth-companies-with-up-to-34-insider-ownership","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/3-asx-growth-companies-with-up-to-34-insider-ownership","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["OZR.AU","XAO.AU","QRE.AU","BK7096","BK7067","BK7110","GYG.AU","E200.AU","OZF.AU","BK7104","TLX.AU","IIGF.AU","TLX","BK7084","IOZ.AU","AV1.AU","BK7016","BK7508","BK7017","IISV.AU","BK4139","AEM.AU","BEAR.AU","VAS.AU","SLF.AU","BBOZ.AU","FRS.AU","VAP.AU","BK7095","QFN.AU","MAF.AU","TOR.AU","EMR.AU","EIGA.AU","BK7137","AR1.AU","XKO.AU","SKS.AU","XJO.AU","IMLC.AU","BK7501","BK7023","PNI.AU","GIVE.AU","STW.AU","SPL.AU","ZYAU.AU","DACE.AU","GEAR.AU","ELS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649659690","title":"Fast Growing Australian Stocks With High Insider Ownership Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2649659690","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649659690?lang=en_us&edition=fundamental","pubTime":"2026-07-05 08:29","pubTimestamp":1783211365,"startTime":"0","endTime":"0","summary":"With inflation trends easing in some regions, interest rate paths looking more measured, and growth signals mixed across major economies, many investors are looking for companies that can rely on their own earnings power rather than broad market momentum. Fast growing stocks with high insider ownership can fit that brief, because management teams have a meaningful stake in the outcome and analysts are optimistic about their prospects. This article profiles 3 stocks from the Fast Growing...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/fast-growing-australian-stocks-with-high-insider-ownership-w-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/fast-growing-australian-stocks-with-high-insider-ownership-w-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EIGA.AU","VAP.AU","GIVE.AU","ZYAU.AU","GLF.AU","OZF.AU","BK7145","TLX","QFN.AU","BK7095","IIGF.AU","BK7067","TLX.AU","SLF.AU","OZR.AU","GEAR.AU","XJO.AU","IOZ.AU","XAO.AU","DACE.AU","BK4139","E200.AU","XKO.AU","VAS.AU","QRE.AU","IISV.AU","BBOZ.AU","STW.AU","BEAR.AU","IMLC.AU","LIN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648565514","title":"Telix Pharmaceuticals Securing FDA Nod in Line With Expectations, Says Jefferies, Shares Down 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648565514","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648565514?lang=en_us&edition=fundamental","pubTime":"2026-07-03 14:06","pubTimestamp":1783058769,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (ASX:TLX) reaching alignment with the US Food and Drug Administration (FDA) to advance a phase 3 trial of its TLX591-Tx therapeutic candidate is in line with expectations, accord","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","TLX.AU","BK7067","BK4585","BK4139","TLX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648410658","title":"Telix Pharmaceuticals (ASX:TLX) Clears FDA Trial Step, Does It Look Fairly Valued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648410658","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648410658?lang=en_us&edition=fundamental","pubTime":"2026-07-03 09:41","pubTimestamp":1783042878,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (ASX:TLX) is back in focus after a Type B meeting with the U.S. Food and Drug Administration confirmed that safety data from its ProstACT Global Phase 3 trial supports moving TLX591-Tx into Part 2.\nSee our latest analysis for Telix Pharmaceuticals.\nAlongside the FDA update, Telix Pharmaceuticals has drawn fresh attention after a strong 30-day share price return of 36.03% and year to date share price return of 51.23%. However, the 1-year total shareholder return declined...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-asxtlx-clears-fda-trial-step-does-it-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-asxtlx-clears-fda-trial-step-does-it-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LABU","BK4588","BK7067","BK4139","TLX","BK4585","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648482680","title":"Jefferies Sees Australia's Telix on Track for Timely U.S. Entry After Prostact FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2648482680","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648482680?lang=en_us&edition=fundamental","pubTime":"2026-07-03 03:25","pubTimestamp":1783020348,"startTime":"0","endTime":"0","summary":"BUZZ-Jefferies sees Australia's Telix on track for timely U.S. entry after ProstACT FDA clearance** Jefferies says Telix’sTLX.AXProstACT trial for prostate cancer is progressing to a timely U.S. entry","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nL6N4342IZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648578493","title":"Telix Pharmaceuticals Says FDA Alignment to Advance Prostact Global Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2648578493","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648578493?lang=en_us&edition=fundamental","pubTime":"2026-07-02 09:46","pubTimestamp":1782956811,"startTime":"0","endTime":"0","summary":"July 2 (Reuters) - Telix Pharmaceuticals Ltd::*FDA ALIGNMENT TO ADVANCE PROSTACT GLOBAL PHASE 3 TRIAL*FDA AND TELIX ALIGN TO ADVANCE PROSTACT GLOBAL PHASE 3 PART 2 IN U.S.*FDA CONFIRMS PART 1 SAFETY D","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nRSD6NGldj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648578138","title":"Australia's Telix Rises to over 9-month High as FDA Backs Prostact Study Advancement","url":"https://stock-news.laohu8.com/highlight/detail?id=2648578138","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648578138?lang=en_us&edition=fundamental","pubTime":"2026-07-02 09:35","pubTimestamp":1782956130,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Telix rises to over 9-month high as FDA backs ProstACT study advancement** Shares of Telix PharmaceuticalsTLX.AXrise as much as 1.9% to A$17.35, hitting their highest level since Sept","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nL4N434031:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648795527","title":"Telix Pharmaceuticals Gets US FDA Nod to Advance Phase 3 Prostate Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2648795527","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648795527?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:37","pubTimestamp":1782952632,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  reached alignment with the US Food and Drug Administration  to advance a phase 3 trial of its TLX591-Tx therapeutic candidate in metastatic castration-resistant prostate cancer, the company said Thursday.In a type B meeting, the US regulator confirmed that safety data from part one of the study is adequate to allow for progression of part two, the company said.The launch of part two in the US remains subject to the FDA's review of an investigational new drug amendment, per the statement.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TLX.AU","LABU","BK4585","BK7067","TLX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648527857","title":"Telix Pharmaceuticals - Initiation of Part 2 in U.S. Subject to FDA Ind Amendment Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2648527857","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648527857?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:07","pubTimestamp":1782950852,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUEQ4M95:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648352785","title":"Telix Pharmaceuticals Ltd-fda Alignment to Advance Prostact Global Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2648352785","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648352785?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:07","pubTimestamp":1782950852,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUEQ4M95:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":198,"code":"91000000","status":"200"}]}}